"The Use of Neupogen (Filgrastim) or Neulasta (Pegfilgrastim) during Pregnancy When Chemotherapy Is Indicated for Maternal Cancer Treatment"
written by Elyce Cardonick, Farhana Irfan, Natalie Torres,
published by Journal of Cancer Therapy, Vol.3 No.2, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Cancer During Pregnancy: The Oncologist Overview
2019
[2] G-CSF and GM-CSF: Clinical Applications in Reproductive Medicine
2019
[3] Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer
2019
[4] Breast cancer and Fertility Part 2-Pregnancy Associated Breast Cancer
2018
[5] A Review of Pregnancy-Associated Breast Cancer: Diagnosis, Local and Systemic Treatment, and Prognosis
2018
[6] Multidisciplinary management of breast cancer during pregnancy
2017
[7] Cancer in pregnancy: safety and efficacy of systemic therapies
Current Opinion in Oncology, 2017
[8] Treatment of Breast Cancer During Pregnancy
Current Breast Cancer Reports, 2017
[9] Tratamiento del cáncer de mama diagnosticado durante el embarazo
2017
[10] Cancer Treatment in Pregnancy
Cancer and Fertility, 2016
[11] Supportive Care During Pregnancy
Managing Cancer during Pregnancy, 2016
[12] Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions
Journal of reproductive immunology, 2015
[13] Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients
JAMA oncology, 2015
[14] Breast cancer in pregnancy: A brief clinical review
Best Practice & Research Clinical Obstetrics & Gynaecology, 2015
[15] Pregnancy-associated breast cancer: optimal treatment options
International journal of women's health, 2014
[16] Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy
Obstetrics & Gynecology, 2012